ECJ Confirms Fine on AstraZeneca for Abusing The Patent and Regulatory Systems
Allen & Overy
December 14, 2012
3 pages
Trending ..... Cybersecurity Proposals ..... ESMA's AIFMD Remuneration Guidance ..... Financial Transactions Tax ..... Model Leniency Program ..... EU Nearer to European Banking Union ..... UsedSoft: CJEU OKs sale of Used Software Licenses ..... The Eurozone Crisis ..... ESMA Consults on Prospectus Directive ..... New Round(s) of Iran Sanctions ..... Apple & E-publishing Giants Under Competition Microscope ..... EC Refreshes Bank State Aid Rules ..... Reform of Data Protection Directive ..... MiFID II ..... EU's MAD Proposal ..... A European Patent? Patent Court? ..... US & EU Sanctions Get Syria-ous ..... Solvency II
ECJ Confirms Fine on AstraZeneca for Abusing The Patent and Regulatory Systems
Allen & Overy
December 14, 2012
3 pages
EU Court of Justice’s AstraZeneca judgment may point to more pro-innovator stance
Sidley Austin
December 13, 2012
3 pages
Judgment of the Court of Justice in AstraZeneca v Commission
Covington & Burling
December 11, 2012
5 pages
ECJ ruling dismisses AstraZeneca's appeal in abuse of dominance case
Herbert Smith Freehills
December 6, 2012
5 pages
CJEU hands down landmark judgment in AstraZeneca competition case
Wragge & Co
December 7, 2012
2 pages
AstraZeneca V. EC — The Advocate General’s Opinion
Covington & Burling
From Law360
May 31, 2012
6 pages
The Advocate General's Opinion in AstraZeneca v. Commission
Covington & Burling
May 17, 2012
5 pages
Taylor Wessing
May 17, 2012
2 pages
Advocate General's Opinion in AstraZeneca appeal published
Herbert Smith
May 17, 2012
3 pages
EU Court of Justice Hears Appeal of Abuse of Dominance Finding Against AstraZeneca
Orrick
January 18, 2012